{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:00:42Z","timestamp":1770620442759,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,10,17]],"date-time":"2004-10-17T00:00:00Z","timestamp":1097971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,10,17]],"date-time":"2004-10-17T00:00:00Z","timestamp":1097971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1038\/nbt1022","type":"journal-article","created":{"date-parts":[[2004,10,24]],"date-time":"2004-10-24T17:04:03Z","timestamp":1098637443000},"page":"1445-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography"],"prefix":"10.1038","volume":"22","author":[{"given":"Jianzhong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S","family":"Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,10,17]]},"reference":[{"key":"BFnbt1022_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jps.2600800216","volume":"80","author":"E Domenici","year":"1991","unstructured":"Domenici, E., Bertucci, C., Salvadori, P. & Wainer, I.W. Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites. J. Pharm. Sci. 80, 164\u2013166 (1991).","journal-title":"J. Pharm. Sci."},{"key":"BFnbt1022_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1520-636X(1999)11:2<115::AID-CHIR6>3.0.CO;2-R","volume":"11","author":"I Fitos","year":"1999","unstructured":"Fitos, I., Visy, J., Simonyi, M. & Hermansson, J. Stereoselective allosteric binding interaction on human serum albumin between ibuprofen and lorazepam acetate. Chirality 11, 115\u2013120 (1999).","journal-title":"Chirality"},{"key":"BFnbt1022_CR3","first-page":"551","volume":"23","author":"JM Stockton","year":"1983","unstructured":"Stockton, J.M., Birdsall, N.J.M., Burgen, A.S.V. & Hulme, E.C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23, 551\u2013557 (1983).","journal-title":"Mol. Pharmacol."},{"key":"BFnbt1022_CR4","first-page":"187","volume":"33","author":"FJ Ehlert","year":"1988","unstructured":"Ehlert, F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33, 187\u2013194 (1988).","journal-title":"Mol. Pharmacol."},{"key":"BFnbt1022_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1042\/bj2090135","volume":"209","author":"U Kragh-Hansen","year":"1983","unstructured":"Kragh-Hansen, U. Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and phenol red on human serum albumin. Biochem. J. 209, 135\u2013142 (1983).","journal-title":"Biochem. J."},{"key":"BFnbt1022_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-3233(08)60410-6","volume":"29","author":"G Weber","year":"1975","unstructured":"Weber, G. Energetics of ligand binding to proteins. Adv. Protein Chem. 29, 1\u201383 (1975).","journal-title":"Adv. Protein Chem."},{"key":"BFnbt1022_CR7","first-page":"7","volume-title":"Drug-Protein Binding","author":"WE Muller","year":"1986","unstructured":"Muller, W.E., Fehske, K.J. & Schlafer, S.A.C. in Drug-Protein Binding (eds. Reidenberg, M.M. & Erill, S.) 7 (Praeger Publishers, New York, 1986)."},{"key":"BFnbt1022_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/bj2250629","volume":"225","author":"U Kragh-Hansen","year":"1985","unstructured":"Kragh-Hansen, U. Relations between high-affinity binding sites of markers for binding regions on human serum albumin. Biochem. J. 225, 629\u2013638 (1985).","journal-title":"Biochem. J."},{"key":"BFnbt1022_CR9","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1021\/ac9903499","volume":"71","author":"A Sengupta","year":"1999","unstructured":"Sengupta, A. & Hage, D.S. Characterization of minor site probes for human serum albumin by high-performance affinity chromatography. Anal. Chem. 71, 3821\u20133827 (1999).","journal-title":"Anal. Chem."},{"key":"BFnbt1022_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-4347(01)00482-0","volume":"768","author":"DS Hage","year":"2002","unstructured":"Hage, D.S. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J. Chromatogr. B 768, 3\u201320 (2002).","journal-title":"J. Chromatogr. B"},{"key":"BFnbt1022_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0378-4347(01)00484-4","volume":"768","author":"R Moaddel","year":"2002","unstructured":"Moaddel, R., Lu, L., Baynham, M. & Wainer, I.W. Immobilized receptor- and transporter-based liquid chromatographic phases for on-line pharmacological and biochemical studies: a mini-review. J. Chromatogr. B 768, 41\u201353 (2002).","journal-title":"J. Chromatogr. B"},{"key":"BFnbt1022_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0006-2952(86)90524-1","volume":"35","author":"I Fitos","year":"1986","unstructured":"Fitos, I. et al. Stereoselective binding of 3-acetoxy-, and 3-hydroxy-1,4-benzodiazepine-2-ones to human serum albumin: selective allosteric interaction with warfarin enantiomers. Biochem. Pharmacol. 35, 263\u2013269 (1986).","journal-title":"Biochem. Pharmacol."},{"key":"BFnbt1022_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/chir.530040106","volume":"4","author":"I Fitos","year":"1992","unstructured":"Fitos, I. & Simonyi, M. Stereoselective effect of phenprocoumon enantiomers on the binding of benzodiazepines to human serum albumin. Chirality 4, 21\u201323 (1992).","journal-title":"Chirality"},{"key":"BFnbt1022_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/chir.10113","volume":"14","author":"I Fitos","year":"2002","unstructured":"Fitos, I., Visy, J. & Kardos, J. Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction. Chirality 14, 442\u2013448 (2002).","journal-title":"Chirality"},{"key":"BFnbt1022_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/mol.59.1.62","volume":"59","author":"L Lu","year":"2001","unstructured":"Lu, L., Leonessa, F., Clarke, R. & Wainer, I.W. Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase. Mol. Pharmacol. 59, 62\u201368 (2001).","journal-title":"Mol. Pharmacol."},{"key":"BFnbt1022_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0378-4347(92)80252-L","volume":"577","author":"TAG Noctor","year":"1992","unstructured":"Noctor, T.A.G., Wainer, I.W. & Hage, D.S. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid chromatography, on a human serum albumin-based stationary phase. J. Chromatogr. 577, 305\u2013315 (1992).","journal-title":"J. Chromatogr."},{"key":"BFnbt1022_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/chir.530020412","volume":"2","author":"E Domenici","year":"1990","unstructured":"Domenici, E., Bertucci, C., Salvadori, P., Motellier, S. & Wainer, I.W. Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions. Chirality 2, 263\u2013268 (1990).","journal-title":"Chirality"},{"key":"BFnbt1022_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0021-9673(94)01009-4","volume":"693","author":"DS Hage","year":"1995","unstructured":"Hage, D.S., Noctor, T.A.G. & Wainer, I.W. Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin. J. Chromatogr. A 693, 23\u201332 (1995).","journal-title":"J. Chromatogr. A"},{"key":"BFnbt1022_CR19","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1021\/ac980734i","volume":"70","author":"DS Hage","year":"1998","unstructured":"Hage, D.S. & Sengupta, A. Studies of protein binding to nonpolar solutes by using zonal elution and high-performance affinity chromatography: interactions of cis- and trans-clomiphene with human serum albumin in the presence of \u03b2-cyclodextrin. Anal. Chem. 70, 4602\u20134609 (1998).","journal-title":"Anal. Chem."},{"key":"BFnbt1022_CR20","first-page":"13","volume":"458","author":"C Lagercrantz","year":"1979","unstructured":"Lagercrantz, C., Larsson, T. & Karlsson, H. Binding of some fatty acids to immobilized bovine serum albumin studied by column affinity chromatography. Anal. Biochem. 458, 13\u201325 (1979).","journal-title":"Anal. Biochem."},{"key":"BFnbt1022_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0378-4347(92)80386-5","volume":"579","author":"B Loun","year":"1992","unstructured":"Loun, B. & Hage, D.S. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin. J. Chromatogr. 579, 225\u2013235 (1992).","journal-title":"J. Chromatogr."},{"key":"BFnbt1022_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0378-4347(94)00547-I","volume":"665","author":"B Loun","year":"1995","unstructured":"Loun, B. & Hage, D.S. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin. J. Chromatogr. B 665, 303\u2013314 (1995).","journal-title":"J. Chromatogr. B"},{"key":"BFnbt1022_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jchromb.2004.06.012","volume":"809","author":"J Chen","year":"2004","unstructured":"Chen, J., Ohnmacht, C. & Hage, D.S. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J. Chromatogr. B 809, 137\u2013145 (2004).","journal-title":"J. Chromatogr. B"},{"key":"BFnbt1022_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.chroma.2004.01.032","volume":"1033","author":"J Chen","year":"2004","unstructured":"Chen, J., Ohnmacht, C.M. & Hage, D.S. Characterization of drug interactions with soluble \u03b2-cyclodextrin by high-performance affinity chromatography. J. Chromatogr. A 1033, 115\u2013126 (2004).","journal-title":"J. Chromatogr. A"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt1022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt1022","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt1022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:36:01Z","timestamp":1684438561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt1022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,17]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11,1]]}},"alternative-id":["BFnbt1022"],"URL":"https:\/\/doi.org\/10.1038\/nbt1022","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,17]]},"assertion":[{"value":"22 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}